Navigation Links
Bortezomib for salvage therapy against progressive myeloma

Despite the initial efficacy of these therapies against multiple myeloma (MM), relapse is invariably the rule. Bortezomib (Velcade, formerly PS-341, Millennium, USA) is a novel first-class agent that inhibits the proteasome, a // multicatalytic cellular enzyme whose activity entails several molecular mechanisms, including, in particular, the NF-kB pathway.

Currently, bortezomib, alone or in combination with dexamethasone and doxorubicin, is under investigation as first-line and maintenance therapy. However, previous studies on advanced disease included a mixture of patients with multiple and heterogeneous previous regimens. Therefore, in order to obtain more careful information about the efficacy and tolerability of this drug in more homogeneously and less heavily pre-treated patients, researchers from Italy focused on the effects of bortezomib on a selected cohort of MM patients who had progressive disease after previous treatments including exclusively AuSCT and thalidomide. They focused on the effects of bortezomib as third line treatment (second salvage therapy) in a very homogeneous group of MM patients induced by AuSCT and relapsed or refractory after thalidomide employed as second line treatment (first salvage therapy).

For the study to be published in the journal Leukemia Research (available online 18 August 2005), twenty-one patients with multiple myeloma, all relapsed after frontline autologous stem cell transplantation and all relapsed again after or resistant to thalidomide (employed as second line treatment) received bortezomib without adjunct of steroids as third line therapy. Three patients died of progressive disease during the first 2 cycles with bortezomib. Eighteen patients received at least 2 cycles and were evaluated for response. According to EBMT criteria, 2 complete (negative immunofixation) and 7 partial remissions were achieved. Duration of response lasted from 2 to 14+ months. Grades 3?4 toxicities (thrombocytopeni a, leucopenia, peripheral neuropathy and vasculitis) were observed in 7 patients, but no patient interrupted the treatment due to side effects.

The study indicates that the use of bortezomib, in this specific setting, is generally safe and may be effective in a relevant proportion of cases. The authors conclude that bortezomib alone may induce high quality responses as third line salvage therapy with acceptable toxicity in a significant proportion of homogeneously pre-treated myeloma patients with progressive disease after autologous transplantation and thalidomide.
'"/>




Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Antioxidants protect health tissue in people undergoing radiation therapy.
3. Distraction therapy found very effective in postoperative patients
4. Acupuncture superseeds massage therapy for short term relief of pain
5. Ovarian cancer in relationship with Hormone therapy
6. New therapy better at increasing bone density
7. Gene therapy - Aim to improve blood flow
8. Gene therapy restores sight
9. Heat therapy relieves back pain
10. Radiotherapy helps in colon cancer
11. New therapy for pimples
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... ... March 22, 2017 , ... University Orthopedics (UOI) today announced ... of Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes ... Orthopedics and Hand Surgery. , As the leader of comprehensive orthopedic care ...
(Date:3/22/2017)... ... 2017 , ... SNL Insurance and Financial, a Virginia based ... in the greater Hampton Roads area, is embarking on a community charity initiative ... , Each year, hundreds of people living in the South Hampton region are ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... assistance, and related services to families and business owners in the greater Nassau ... the Leukemia & Lymphoma Society. , Every 3 minutes, someone in America is ...
(Date:3/22/2017)... Toronto, CANADA (PRWEB) , ... March 22, 2017 , ... ... Indiegogo today, the Sweep&Stand. The conventional broom was great when it was invented, ... They are the working parents, the social young couple, the empty nesters and ...
(Date:3/22/2017)... ... ... The National Association for Business Resources (NABR) has recently named ... Wellness® companies for 2017. , American Specialty Health (ASH) was honored for ... its employees. ASH is one of only nine other San Diego companies being recognized ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Kentucky , March 22, 2017 ... and Manufacturing Organization (CDMO), held a special event to ... facilities in Lexington, Kentucky . The ... , Piramal Group Chairman Ajay Piramal, and Piramal ... ...
(Date:3/22/2017)... Mass. , March 22, 2017 Hologic, ... it has completed the acquisition of Cynosure, Inc., a ... per share in cash. "We are pleased ... to working with Michael Davin and the ... the large, rapidly growing medical aesthetics market," said ...
(Date:3/22/2017)... , March 22, 2017 FinancialBuzz.com ... growing legal cannabis industry is strongly contributing to job ... comprehensive analysis and reporting for the cannabis industry, projects ... more than a quarter million jobs for American workers. ... billion in 2016, and is projected to grow at ...
Breaking Medicine Technology: